Lineage Cell Therapeutics (LCTX) Market Cap to FCF (2009 - 2026)
Lineage Cell Therapeutics (LCTX) Market Cap to FCF (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Market Cap to FCF |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -5.37 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -3.22 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -37,563.72 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -169,108.42 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -8,971.08 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 30.34 |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -636.65 |
| 10 | Lineage Cell Therapeutics | 297.71 Mn | 233.81 Mn | 1.73 Mn | -13.17 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 8, 2026 | -13.17 |
| Jun 5, 2026 | -12.90 |
| Jun 4, 2026 | -13.12 |
| Jun 3, 2026 | -13.01 |
| Jun 2, 2026 | -13.12 |
| Jun 1, 2026 | -13.71 |
| May 29, 2026 | -14.42 |
| May 28, 2026 | -14.42 |
| May 27, 2026 | -14.09 |
| May 26, 2026 | -13.98 |
| May 22, 2026 | -14.09 |
| May 21, 2026 | -14.36 |
| May 20, 2026 | -13.93 |
| May 19, 2026 | -13.17 |
| May 18, 2026 | -13.49 |
| May 15, 2026 | -13.55 |
| May 14, 2026 | -14.15 |
| May 13, 2026 | -13.87 |
| May 12, 2026 | -14.42 |
| May 11, 2026 | -14.20 |